Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
1.980
-0.050 (-2.46%)
At close: Jun 1, 2026, 4:00 PM EDT
1.970
-0.010 (-0.51%)
After-hours: Jun 1, 2026, 7:47 PM EDT
Microbot Medical Employees
Microbot Medical had 43 employees as of December 31, 2025. The number of employees increased by 23 or 115.00% compared to the previous year.
Employees
43
Change (1Y)
23
Growth (1Y)
115.00%
Revenue / Employee
$2,442
Profits / Employee
-$330,512
Market Cap
132.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 43 | 23 | 115.00% | 43 | 0 |
| Dec 31, 2024 | 20 | -2 | -9.09% | 20 | 0 |
| Dec 31, 2023 | 22 | 4 | 22.22% | 21 | 1 |
| Dec 31, 2022 | 18 | -2 | -10.00% | 18 | 0 |
| Dec 31, 2021 | 20 | 6 | 42.86% | 20 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Embecta | 1,850 |
| OraSure Technologies | 500 |
| Pro-Dex | 181 |
| Nyxoah | 154 |
| Utah Medical Products | 152 |
| Stereotaxis | 131 |
| Sanara MedTech | 108 |
| Precision Optics Corporation | 90 |
MBOT News
- 6 days ago - Microbot Medical announces Israel granted marketing clearance for Liberty - TheFly
- 6 days ago - Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System - GlobeNewsWire
- 17 days ago - Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu - GlobeNewsWire
- 18 days ago - Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 - GlobeNewsWire
- 27 days ago - Microbot Medical®'s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites - GlobeNewsWire
- 4 weeks ago - Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA) - GlobeNewsWire
- 5 weeks ago - Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY® - GlobeNewsWire
- 6 weeks ago - Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire